CD4 and tuberculosis: For those taking CTX at CD4 101 to 200 cells/μL, there was a 44% reduction in the hazard for development of TB (HR = 0.56, 95% CI (0.33 to 0.94), p = 0.03) compared to those no receiving CTX.